Mutations in HBV DNA polymerase associated with nucleos(t)ide resistance are rare in treatment-naive patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Gastroenterology and Hepatology

• Publication date

  2014-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.cgh.2013.11.036PMID 24342744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra‐deep pyrosequencing

  2013cited by this paper
• Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study

  2011cited by this paper
• Large‐scale survey of naturally occurring HBV polymerase mutations associated with anti‐HBV drug resistance in untreated patients with chronic hepatitis B

  2011cited by this paper
• The efficacy of entecavir therapy in chronic hepatitis B patients with suboptimal response to adevofir

  2011cited by this paper
• Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.

  2011cited by this paper
• Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.

  2010cited by this paper
• Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-naïve Chinese patients.

  2010cited by this paper
• Natural history of chronic hepatitis B.

  2010cited by this paper
• Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.

  2009cited by this paper
• Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients

  2009cited by this paper
• Variability of HBV reverse transcriptase and overlapping S gene in viral isolates from untreated and lamivudine-resistant chronic hepatitis B patients

  2009cited by this paper
• Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

  2009cited by this paper
• Hepatitis B virus resistance to nucleos(t)ide analogues.

  2009cited by this paper
• Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden

  2009cited by this paper
• Prevalence of hepatitis B virus DNA polymerase mutations in treatment‐naïve patients with chronic hepatitis B

  2009cited by this paper
• EFFECTIVENESS OF ENTECAVIR FOR THE TREATMENT OF NUC-NAÏVE CHRONIC HEPATITIS B PATIENTS: A LARGE MULTICENTER COHORT STUDY IN CLINICAL PRACTICE

  2009cited by this paper
• Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.

  2008cited by this paper
• Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients

  2008cited by this paper
• A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.

  2008cited by this paper
• Chronic hepatitis B: preventing, detecting, and managing viral resistance.

  2008cited by this paper
• Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.

  2008cited by this paper
• Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure

  2008cited by this paper
• Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir.

  2007cited by this paper
• The natural history of chronic hepatitis B

  2007cited by this paper
• Variant of hepatitis B virus with primary resistance to adefovir.

  2006cited by this paper
• Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.

  2006cited by this paper
• YMDD motif variants in inactive hepatitis B carriers detected by Inno‐Lipa HBV DR assay

  2006cited by this paper
• Assessment and management of chronic hepatitis B.

  2006cited by this paper
• Hepatitis B virus with primary resistance to adefovir.

  2006cited by this paper
• Prevalence, Incidence, and Clinical Relevance of the Reverse Transcriptase V207I Mutation Outside the YMDD Motif of the Hepatitis B Virus Polymerase during Lamivudine Therapy

  2005cited by this paper
• YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.

  2005cited by this paper
• The Clinical Impact of Early Detection of the Ymdd Mutant on the Outcomes of Long-Term Lamivudine Therapy in Patients with Chronic Hepatitis B

  2005cited by this paper
• Lamivudine for patients with chronic hepatitis B and advanced liver disease.

  2004cited by this paper
• Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine

  2003cited by this paper
• Comparison of Sequence Analysis and the INNO-LiPA HBV DR Line Probe Assay for Detection of Lamivudine-Resistant Hepatitis B Virus Strains in Patients under Various Clinical Conditions

  2001cited by this paper
• Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.

  2001cited by this paper

• Expanding the Donor Pool for Liver Transplantation: Assessing the Potential Use of HBV-Positive Allografts

  2024cites this paper
• Investigation of mutations in the partial sequences of the surface and polymerase genes of hepatitis B virus associated with immune escape and drug resistance in HIV-infected patients

  2023cites this paper
• Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil

  2022cites this paper
• Cross-sectional retrospective analysis of clinical characteristics of chronic hepatitis B patients with oral antiviral treatment in eastern China

  2021cites this paper
• Distribution of Hepatitis B Virus Genotypes, Subgenotypes, and Prevalence of Hepatitis B Virus Mutations in Untreated Patients With Chronic Hepatitis B From Mekong Delta

  2021cites this paper
• Differential Effectiveness of Tenofovir and Entecavir for Prophylaxis of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Depending on Coexisting Cirrhosis and Prior Exposure to Antiviral Therapy

  2021cites this paper
• Prevalence of Potential Resistance Related Variants Among Chinese Chronic Hepatitis B Patients Not Receiving Nucleos(T)ide Analogues

  2020cites this paper
• Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients

  2020cites this paper
• Evaluation of Hepatitis B Virus Nucleos(t)ide Analogues Resistance mutations in Treatment-Naïve Patients: A Systematic Review and Meta-Analysis

  2020influential citation
• Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients

  2019cites this paper
• Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients

  2019cites this paper
• Integrative Gastroenterology and Hepatology Retrospective Analysis of HBV Pre-Existing Mutations and Drug-induced Resistance Mutations in Patients with Hepatitis B Virus-Related Cirrhosis

  2019cites this paper
• Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure

  2019cites this paper
• An Overview of Hepatitis B Virus Surface Antigen Secretion Inhibitors

  2018cites this paper
• Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression

  2018cites this paper
• Molecular Characterization of Drug Resistance in Hepatitis B Viruses Isolated from Patients with Chronical Infection in Turkey

  2018cites this paper
• Hepatitis B virus pre-existing drug resistant mutation is related to the genotype and disease progression.

  2017cites this paper
• Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment

  2017cites this paper
• Hepatitis B Virus Drug Resistance

  2017cites this paper
• Analysis of Naturally Occurring Mutations in Reverse Transcriptase Region of Hepatitis B Virus Genotype C2 Polymerase

  2017cites this paper
• Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naïve Korean patients infected with genotype C2

  2017cites this paper
• HBV Drug Resistance Substitutions Existed before the Clinical Approval of Nucleos(t)ide Analogues: A Bioinformatic Analysis by GenBank Data Mining

  2017influential citation
• Prevalence of mutations in HBV DNA polymerase gene associated with nucleos(t)ide resistance in treatment-naive patients with Chronic Hepatitis B in Central China

  2016cites this paper
• Response to potent anti-HBV agents in chronic hepatitis B and combined effect of HBV reverse transcriptase mutations.

  2015cites this paper
• Advances in treating drug-resistant hepatitis B virus in HIV-infected patients

  2015cites this paper
• Incidence of natural resistance mutations in naïve chronic hepatitis B patients: A systematic review and meta‐analysis

  2015cites this paper
• Investigation into Drug-Resistant Mutations of HBV from 845 Nucleoside/Nucleotide Analogue-Naive Chinese Patients with Chronic HBV Infection

  2015cites this paper
• Molecular diagnosis and treatment of drug-resistant hepatitis B virus.

  2014cites this paper
• Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis B.

  2014cites this paper
• Management and treatment of chronic hepatitis B in HIV-positive patients

  2014cites this paper
• Hemochromatosis

  1966cites this paper